Clinical Trials Directory

Trials / Unknown

UnknownNCT05091697

Cost-utility of VIRTUAL FIBROWALK

Cost-utility of the Multicomponent Program VIRTUAL FIBROWALK in Patients With Fibromyalgia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
142 (actual)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to assess the effectiveness and cost-utility of the VIRTUAL FIBROWALK multicomponent treatment program as coadjuvant of treatment-as- usual (TAU) compared to TAU alone.

Detailed description

This is a two-arm RCT focused on the effectiveness and cost-utility of the multicomponent program VIRTUAL FIBROWALK as coadjuvant of treatment-as- usual (TAU) vs. TAU alone (in a 3-month follow-up RCT) VIRTUAL FIBROWALK combines multicomponent approach based on Pain Neuroscience Education (PNE), therapeutic exercise, Cognitive Behavioural Therapy (CBT) and Mindfulness training.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMulticomponent treatment VIRTUAL FIBROWALK + TAUTo assess the effectiveness and cost-utility of the virtual multicomponent program (Fibrowalk)

Timeline

Start date
2021-04-26
Primary completion
2021-12-10
Completion
2021-12-30
First posted
2021-10-25
Last updated
2021-12-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05091697. Inclusion in this directory is not an endorsement.

Cost-utility of VIRTUAL FIBROWALK (NCT05091697) · Clinical Trials Directory